ConvaTec Group PLC (LON: CTEC) recently received a number of ratings updates from brokerages and research firms:

  • 3/7/2017 – ConvaTec Group PLC had its price target raised by analysts at Goldman Sachs Group Inc from GBX 300 ($3.71) to GBX 310 ($3.83). They now have a “buy” rating on the stock.
  • 3/6/2017 – ConvaTec Group PLC had its price target raised by analysts at Deutsche Bank AG from GBX 275 ($3.40) to GBX 300 ($3.71). They now have a “buy” rating on the stock.
  • 3/3/2017 – ConvaTec Group PLC had its price target raised by analysts at Credit Suisse Group AG from GBX 250 ($3.09) to GBX 275 ($3.40). They now have a “neutral” rating on the stock.
  • 3/3/2017 – ConvaTec Group PLC had its price target raised by analysts at JPMorgan Chase & Co. from GBX 271 ($3.35) to GBX 305 ($3.77). They now have an “overweight” rating on the stock.
  • 3/2/2017 – ConvaTec Group PLC had its “buy” rating reaffirmed by analysts at Peel Hunt. They now have a GBX 300 ($3.71) price target on the stock.
  • 2/27/2017 – ConvaTec Group PLC had its “buy” rating reaffirmed by analysts at Deutsche Bank AG.
  • 2/24/2017 – ConvaTec Group PLC had its “buy” rating reaffirmed by analysts at Peel Hunt. They now have a GBX 300 ($3.71) price target on the stock.
  • 1/19/2017 – ConvaTec Group PLC is now covered by analysts at HSBC Holdings plc. They set a “buy” rating and a GBX 310 ($3.83) price target on the stock.

ConvaTec Group PLC (LON:CTEC) traded down 0.42% during midday trading on Monday, hitting GBX 259.70. The stock had a trading volume of 2,069,410 shares. The firm’s market cap is GBX 3.57 billion. ConvaTec Group PLC has a 52 week low of GBX 213.00 and a 52 week high of GBX 263.50. The stock has a 50-day moving average of GBX 245.79 and a 200-day moving average of GBX 241.65.

ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.

Receive News & Ratings for ConvaTec Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.